Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-12-13
2005-12-13
Shameem, Golam M M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S190000, C548S193000, C548S194000
Reexamination Certificate
active
06974830
ABSTRACT:
The present invention relates to compounds according to the general formula (I) which bind to the NR1H4 receptor and act as agonists of the NR1H4 receptor. The invention further relates to the treatment of diseases and/or conditions through binding of the nuclear receptor by the compounds and the production of medicaments using the compounds.
REFERENCES:
patent: 2863874 (1958-12-01), Gregory
patent: 5464847 (1995-11-01), Courtemanche et al.
patent: 5602132 (1997-02-01), Roger et al.
patent: 5668161 (1997-09-01), Talley et al.
patent: 5856347 (1999-01-01), Hashiguchi et al.
patent: 6051574 (2000-04-01), Anthony
patent: 09-235278 (1997-09-01), None
Gregory et al (1958): STN International CAPLUS database, Columbus (Ohio),Accession No., 1959:51205.
Bauer Ulrike
Cheruvallath Zach
Deuschle Ulrich
Dneprovskaia Elena
Gahman Tim
Phenix Pharmaceuticals AG
Saliwanchik Lloyd & Saliwanchik
Shameem Golam M M
LandOfFree
NR1H4 nuclear receptor binding compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with NR1H4 nuclear receptor binding compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NR1H4 nuclear receptor binding compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3520948